Zylo Therapeutics Inc.

Pharmaceutical company · Greenville, South Carolina, United States

Zylo Therapeutics Inc. is a pharmaceutical company headquartered in Greenville, South Carolina, United States. Its earliest recorded incorporation is in 2017. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2021.

www.zylotherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Zylo Therapeutics at a glance

Typepharmaceutical company
HeadquartersGreenville, South Carolina, United States
Earliest incorporation on record2017
Employees (self-reported, 2025)5
SEC CIK1721431

What does Zylo Therapeutics do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2019 to 2025). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $1.5 million sold (2021).

Frequently asked questions about Zylo Therapeutics

Where is Zylo Therapeutics headquartered?

Zylo Therapeutics Inc. is headquartered in Greenville, South Carolina, United States.

What does Zylo Therapeutics do?

Zylo Therapeutics Inc. is a pharmaceutical company.

When was Zylo Therapeutics founded?

The earliest incorporation on record for Zylo Therapeutics Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences